Reply: Labeling and Drug Safety of Loperamide: Time for a Proactive Approach?

Mark C. Haigney; Michael G. Klein; Thomas P. Flagg; Naheed Fatima; Philip S. Mehler; Mori J. Krantz

doi:10.1016/j.jacep.2017.03.001

Reply: Labeling and Drug Safety of Loperamide: Time for a Proactive Approach?

Mark C. Haigney, Michael G. Klein, Thomas P. Flagg, Naheed Fatima, Philip S. Mehler, Mori J. Krantz^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	422-423
Number of pages	2
Journal	JACC: Clinical Electrophysiology
Volume	3
Issue number	4
DOIs	https://doi.org/10.1016/j.jacep.2017.03.001
State	Published - Apr 2017

Access to Document

10.1016/j.jacep.2017.03.001

Cite this

@article{ef7264fb43d3425092f9e4e4c8fd9649,

title = "Reply: Labeling and Drug Safety of Loperamide: Time for a Proactive Approach?",

author = "Haigney, \{Mark C.\} and Klein, \{Michael G.\} and Flagg, \{Thomas P.\} and Naheed Fatima and Mehler, \{Philip S.\} and Krantz, \{Mori J.\}",

year = "2017",

month = apr,

doi = "10.1016/j.jacep.2017.03.001",

language = "English",

volume = "3",

pages = "422--423",

journal = "JACC: Clinical Electrophysiology",

issn = "2405-500X",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Reply

T2 - Labeling and Drug Safety of Loperamide: Time for a Proactive Approach?

AU - Haigney, Mark C.

AU - Klein, Michael G.

AU - Flagg, Thomas P.

AU - Fatima, Naheed

AU - Mehler, Philip S.

AU - Krantz, Mori J.

PY - 2017/4

Y1 - 2017/4

UR - http://www.scopus.com/inward/record.url?scp=85018429038&partnerID=8YFLogxK

U2 - 10.1016/j.jacep.2017.03.001

DO - 10.1016/j.jacep.2017.03.001

M3 - Letter

C2 - 29759459

AN - SCOPUS:85018429038

SN - 2405-500X

VL - 3

SP - 422

EP - 423

JO - JACC: Clinical Electrophysiology

JF - JACC: Clinical Electrophysiology

IS - 4

ER -

Reply: Labeling and Drug Safety of Loperamide: Time for a Proactive Approach?

Access to Document

Fingerprint

Cite this